Onco3R Therapeutics reports first pre-clinical data from its best-in-class precision ...

Three posters to be presented featuring pre-clinical data of potential best-in-class FGFR3 selective inhibitor, SMARCA2 selective inhibitor, and ...
腾讯网

同行致远 | 攻克“不可成药”，精准抗癌疗法迎来新篇章 | Bilingual

编者按：近年来，合成致死（synthetic ...